Mnemo Therapeutics
About:
Mnemo Therapeutics specializes in biotechnology and life science.
Website: https://www.mnemo-tx.com/
Twitter/X: MnemoTx
Top Investors: Sofinnova Partners, Alexandria Venture Investments, Casdin Capital, Emerson Collective, Redmile Group
Description:
Mnemo Therapeutics is a biotechnology company that offers to develop immune based therapies, including cell therapies. Its EnfiniT platform is a drug discovery engine that uses a class of antigens with a suite of technologies for tumors.
Total Funding Amount:
75M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2019-01-01
Founders:
Alain Maiore
Number of Employees:
51-100
Last Funding Date:
2021-06-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai